Abstract
Lenalidomide Plus Bortezomib and Dexamethasone in the Treatment of Newly Diagnosed Multiple Myeloma: Results from a Canadian Cost-Effectiveness Analysis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have